Sustained release fluoride composition

Details Sustained release fluoride composition Sustained release fluoride composition

1986-09-25

1989-08-22

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Phosphorus or phosphorus compound

424468, 424469, 424676, A61K 922, A61K 926, A61K 3316

Patent

active

048594679

ABSTRACT:
A medication for providing fluoride ion for the prevention and treatment of bone loss disease. The dosage is a lozenge, tablet or capsule containing from 20 to 100 milligrams of sodium monofluorophosphate and further includes a slow release mechanism for controlling release of the fluoride ion over a period of up to eight hours after swallowing. Up to ten percent of sodium fluoride can be added.

REFERENCES:
patent: 2449184 (1948-09-01), Strean
patent: 2627493 (1953-02-01), Merckel et al.
patent: 2967131 (1961-01-01), Elbreder et al.
patent: 3119743 (1964-01-01), Ericsson
patent: 3312594 (1967-04-01), Cyr et al.
patent: 3431339 (1969-03-01), Gyarmathy et al.
patent: 4169885 (1979-10-01), Raaf et al.
patent: 4265877 (1981-05-01), Tenta et al.
patent: 4726952 (1988-02-01), Walsoorf et al.
patent: 4728513 (1988-03-01), Ventouras
Eisch CA.89:12151a (1978).
Jowsey CA.89:122856s (1978).
Becker GA.90:132993u (1979).
Erickson CA.90: 180340a (1979).
Fuchs CA.91:186370c (1979).
White CA.99:200373e (1983).
Baylink CA.99:205347a (1983).
Anderson CA.104:45750e, 45761f (1986).

Affiliated with

Also associated with

Rating

Sustained release fluoride composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release fluoride composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release fluoride composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2416938